<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90560">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01705353</url>
  </required_header>
  <id_info>
    <org_study_id>12-090B</org_study_id>
    <nct_id>NCT01705353</nct_id>
  </id_info>
  <brief_title>The Role of HMGB-1 in Chronic Stroke</brief_title>
  <official_title>Pilot Study of the Role of HMGB-1 in Retarding Recovery in Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Shore Long Island Jewish Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Shore Long Island Jewish Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the presence of HMGB-1 and other proteins  in the
      blood across five time points after stroke, and to determine if their presence correlates
      with rate of stroke recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke, cerebrovascular accident, is the leading cause of brain injury and the leading cause
      of permanent disability. The acute pathophysiology of stroke depends on the innate immune
      response, which arises from mostly pro-inflammatory cascades. The chronic pathophysiology of
      stroke is less clear as the innate inflammatory response fades and matures into an adaptive
      immune response.  HMGB-1 is a serum cytokine that has been found with persistent elevated
      levels for weeks to months after neurological insult in preclinical experiments, and may
      retard functional recovery. Elucidation of the relationship between HMGB-1 levels and the
      rate of functional recovery after stroke could lead to a better understanding of the
      systemic inflammatory response and more targeted therapeutic interventions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Cytokine levels (HMGB-1) in plasma samples</measure>
    <time_frame>day 1, day7, day 14, day 30, day 90</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>NIH and Rankin Clinical Measures of functional recovery</measure>
    <time_frame>day 1, day7, day 14, day 30, day 90</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cerebrovascular Accident</condition>
  <condition>Cerebral Stroke</condition>
  <condition>Stroke, Acute</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, DNA, serum/serum cytokines
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Acute care hospital (stroke unit)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to the stroke service at Northshore and LIJ Medical Centers

          -  Patients 18 years of age or older

        Exclusion Criteria:

          -  Patients &lt; 18 years of age
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce T Volpe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Feinstein Institute for Medical Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruce T Volpe, MD</last_name>
    <phone>516-562-3384</phone>
    <email>bvolpe1@nshs.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Johanna Chang, MS</last_name>
    <phone>516-562-3646</phone>
    <email>jchang14@nshs.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, Bendszus M, Rossetti G, Nawroth PP, Bierhaus A, Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci. 2008 Nov 12;28(46):12023-31.</citation>
    <PMID>19005067</PMID>
  </reference>
  <reference>
    <citation>Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, Lesser ML, Church AL, Litroff AH, Sama AE, Tracey KJ. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 2006 Jun;25(6):571-4.</citation>
    <PMID>16721263</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 16, 2014</lastchanged_date>
  <firstreceived_date>October 9, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Shore Long Island Jewish Health System</investigator_affiliation>
    <investigator_full_name>Bruce Volpe</investigator_full_name>
    <investigator_title>Investigator (MD)</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Cerebrovascular Accident</keyword>
  <keyword>HMGB-1</keyword>
  <keyword>cytokines</keyword>
  <keyword>functional recovery</keyword>
  <keyword>inflammation</keyword>
  <keyword>immune response</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
